TOP TIERMARKET NEWSWIRE

News & sentiment

KAMADA LTD (KMDA) — News & AI sentiment

KAMADA LTD (KMDA) news roundup. 6 stories aggregated over the last 30 days. Average 30-day sentiment is 59/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 2 sales totalling $1.7M — net selling of $1.7M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

0

30d stories

6

avg sentiment 59/100

Insider net (90d)

$1.7M

0 buys · 2 sells

Congress (90d)

0

0 buys · 0 sells

KMDA news in the last 24 hours, 7 days, 30 days and 90 days

How much KMDA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	KMDA stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	0	—	no coverage
Last 30 days	6	59/100	KMDA headlines →
Last 90 days	34	58.3/100	KMDA headlines →

Latest stories on KMDA

Kamada Announces Participation in the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London During November 2026

GlobeNewswire52 · neutralproduct/pr

Oct 19

Kamada Announces Participation in the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London During November 2026

Business Insider52 · neutralproduct/pr

Oct 19

Kamada broadens Israel biosimilars lineup with two interchangeable launches and outlines a 12-product goal by 2030 October 7, 2026

MarketChameleon63 · neutralproduct/pr

Oct 7

Stifel reiterates Kamada stock Buy rating on biosimilar expansion

Investing.com Analyst Ratings61 · neutralanalyst

Oct 6

Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel

GlobeNewswire63 · neutralproduct/pr

Oct 6

Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel

Business Insider63 · neutralproduct/pr

Oct 6

StoneX reiterates Kamada stock buy rating on rabies treatment supply

Investing.com Analyst Ratings61 · neutralanalyst

Sep 18

Kamada says KedRAB supplies are adequate as rabies cases rise in U.S.

Seeking Alpha63 · neutralproduct/pr

Sep 17

Kamada confirms sufficient KedRAB supply amid increased demand

The Fly63 · neutralproduct/pr

Sep 17

CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand

GlobeNewswire67 · bullishproduct/pr

Sep 17

CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand

Business Insider67 · bullishproduct/pr

Sep 17

Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference

StockTitan56 · neutralgeneral

Sep 10

Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire56 · neutralgeneral

Sep 10

Kamada files to sell $50M of ordinary shares

The Fly24 · bearishgeneral

Sep 9

Kamada declares $0.17 dividend

Seeking Alpha50 · neutralgeneral

Sep 4

Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders

GlobeNewswire50 · neutralgeneral

Sep 3

Kamada (KMDA) Q2 2026 Earnings Call Transcript

Yahoo Top73 · bullishearnings

Aug 19

Kamada (KMDA) Q2 2026 Earnings Call Transcript

The Motley Fool73 · bullishearnings

Aug 19

Kamada declares $0.17 dividend

Seeking Alpha50 · neutralgeneral

Aug 17

Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026

GlobeNewswire59 · neutralgeneral

Aug 17

Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026

Business Insider59 · neutralgeneral

Aug 17

Kamada Ltd. Q2 2026 Earnings Call Summary

Yahoo Top50 · neutralearnings

Aug 12

Kamada Ltd. (KMDA) Q2 2026 Earnings Call Transcript

Seeking Alpha50 · neutralearnings

Aug 12

Kamada Q2 Earnings Call Highlights

Yahoo Finance67 · bullishearnings

Aug 12

Kamada Posts Record Revenues and Double-Digit Profit Growth, Affirms 2026 Guidance Amid Portfolio Expansion August 12, 2026

MarketChameleon76 · bullishearnings

Aug 12

Open KMDA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →